Background Immune exhaustion and senescence are dominant dysfunctional states of effector T cells and major hurdles for the success of cancer immunotherapy. In the current study, we characterized how acute myeloid leukemia (AML) promotes the generation of senescent-like CD8+ T cells and whether they have prognostic relevance.METHODS We analyzed NanoString, bulk RNA-Seq and single-cell RNA-Seq data from independent clinical cohorts comprising 1,896 patients treated with chemotherapy and/or immune checkpoint blockade (ICB).Results We show that senescent-like bone marrow CD8+ T cells were impaired in killing autologous AML blasts and that their proportion negatively correlated with overall survival (OS). We defined what we believe to be new immune effector dysfunction (IED) signatures using 2 gene expression profiling platforms and reported that IED scores correlated with adverse-risk molecular lesions, stemness, and poor outcomes; these scores were a more powerful predictor of OS than 2017-ELN risk or leukemia stem cell (LSC17) scores. IED expression signatures also identified an ICB-unresponsive tumor microenvironment and predicted significantly shorter OS.Conclusion The IED scores provided improved AML-risk stratification and could facilitate the delivery of personalized immunotherapies to patients who are most likely to benefit.TRIAL REGISTRATION ClinicalTrials.gov; NCT02845297.FUNDING John and Lucille van Geest Foundation, Nottingham Trent University’s Health & Wellbeing Strategic Research Theme, NIH/NCI P01CA225618, Genentech-imCORE ML40354, Qatar National Research Fund (NPRP8-2297-3-494).
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung-On Yau, Rupkatha Mukhopadhyay, Benjamin Dickins, Heidi Altmann, Michael Kramer, Hanna A. Knaus, Bruce R. Blazar, Vedran Radojcic, Joshua F. Zeidner, Andrea Arruda, Bofei Wang, Hussein A. Abbas, Mark D. Minden, Sarah K. Tasian, Martin Bornhäuser, Ivana Gojo, Leo Luznik
Title and authors | Publication | Year |
---|---|---|
Delineating circulating lymphocyte subsets in the transition from gout remission to recurrence
Hanjie Yu, Ling Wang, Ling Qin, Hanqing Yu, Ran Hu, Zhenghu Jia, Hui Bao, Haichao Wang, Wen Xue, Yaxiang Song, Zhinan Yin, Ai Peng |
Frontiers in immunology | 2025 |
Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization
Zhao J, Yu Y, Liu C, Liu R, Sun M, Zhuang J, Sun C, Wu Q |
Journal of Cancer | 2025 |
The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Tasis A, Spyropoulos T, Mitroulis I |
Cancers | 2025 |
CD69 predicts prognosis through immune cell infiltration and decitabine treatment response in acute myeloid leukemia
Zhou J, Wu H, Li B, Lv L, Zhu S, Liang A, Fu J |
Translational Cancer Research | 2025 |
Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity
Cui J, Liu W, Zhong S, Fang Y, Xu P, Xu C, Wang R, Hu X, Zhou W, Li K, Hong M, Qian S, Sun Q |
Cancer Immunology, Immunotherapy : CII | 2025 |
Therapeutic Hurdles in Acute Myeloid Leukemia: Leukemic Stem Cells, Inflammation and Immune Dysfunction
Wang B, Reville PK, Abbas HA |
Current opinion in pharmacology | 2025 |
Mendelian randomization analysis reveals the causal relationship between immune cells and leukemia.
Lin Y, Shi S, Song J, Liu S |
Discover oncology | 2025 |
Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia
Wang M, Xian H, Xia X, Zhang W, Huang Z, Lu C, Zheng Y, Wang Y, Xie S, Pan R, Yu Y, Wang R, Zheng H, Huang G, Liu H |
Journal of Translational Medicine | 2025 |
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Mazziotta F, Martin LE, Egan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung CC, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG |
Nature Communications | 2025 |
CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
Zhong F, Yao F, Jiang J, Yu X, Liu J, Huang B, Wang X |
Inflammation research : official journal of the European Histamine Research Society ... [et al.] | 2024 |
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
Towers R, Trombello L, Fusenig M, Tunger A, Baumann AL, Savoldelli R, Wehner R, Fasslrinner F, Arndt C, Dazzi F, Von Bonin M, Feldmann A, Bachmann MP, Wobus M, Schmitz M, Bornhäuser M |
Cancer Immunology, Immunotherapy | 2024 |
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance.
Liu J, Jiang P, Lu Z, Yu Z, Qian P |
Experimental Hematology and Oncology | 2024 |
Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Root JL, Desai PN, Ly C, Wang B, Jelloul FZ, Zhou J, Mackay S, Alfayez M, Matthews J, Pierce S, Reville PK, Daver N, Abbas HA |
2024 | |
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.
Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, Vaughn NR, Baran N, Deng Q, Matthews J, Gunaratne PH, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, Abbas HA |
Nature Communications | 2024 |
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML
Bauer M, Jäkel N, Wilfer A, Haak A, Eszlinger M, Kelemen K, Haemmerle M, Al-Ali HK, Seliger B, Wickenhauser C |
OncoImmunology | 2024 |
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
Santoro N, Salutari P, Di Ianni M, Marra A |
International journal of molecular sciences | 2024 |
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Sayitoglu EC, Luca BA, Boss AP, Thomas BC, Freeborn RA, Uyeda MJ, Chen PP, Nakauchi Y, Waichler C, Lacayo N, Bacchetta R, Majeti R, Gentles AJ, Cepika AM, Roncarolo MG |
Leukemia | 2024 |
IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype
Wang L, Wei Y, Jin Z, Liu F, Li X, Zhang X, Bai X, Jia Q, Zhu B, Chu Q |
Clinical and Experimental Medicine | 2024 |
Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia.
Ma C, Hao Y, Shi B, Wu Z, Jin D, Yu X, Jin B |
Cancer Gene Therapy | 2024 |
Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia
Restelli C, Ruella M, Paruzzo L, Tarella C, Pelicci PG, Colombo E |
2024 | |
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain SS, Burton Sojo G, Sun H, Friedland BN, McNamara ME, Schmidt MO, Wellstein A |
International journal of molecular sciences | 2024 |
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View
Mosna F |
Cancers | 2024 |
Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures
Li XP, Song JT, Dai YT, Zhang WN, Zhao BT, Mao JY, Gao Y, Jiang L, Liang Y |
Frontiers in immunology | 2024 |
High temporal resolution prediction of mortality risk for single AML patient via deep learning
Lei Y, Wei H, Gao X |
iScience | 2024 |
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.
Koedijk JB, van der Werf I, Penter L, Vermeulen MA, Barneh F, Perzolli A, Meesters-Ensing JI, Metselaar DS, Margaritis T, Fiocco M, de Groot-Kruseman HA, Moeniralam R, Bang Christensen K, Porter B, Pfaff K, Garcia JS, Rodig SJ, Wu CJ, Hasle H, Nierkens S, Belderbos ME, Zwaan CM, Heidenreich O |
Leukemia | 2024 |
Immune-dysregulation harnessing in myeloid neoplasms.
Sharifi MJ, Xu L, Nasiri N, Ashja-Arvan M, Soleimanzadeh H, Ganjalikhani-Hakemi M |
Cancer medicine | 2024 |
CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia
Mazziotta F, Biavati L, Rimando J, Rutella S, Borcherding N, Parbhoo S, Mukhopadhyay R, Chowdhury S, Knaus HA, Valent P, Hackl H, Borrello IM, Blazar BR, Hatzi K, Gojo I, Luznik L |
Blood | 2024 |
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse
Kazerani M, Marcinek A, Philipp N, Brauchle B, Taylor JJ, Moreno HD, Terrasi A, Tast B, Rohrbacher L, Wang Y, Warm M, Emhardt AJ, Magno G, Spiekermann K, Herold T, Straub T, Theurich S, Schotta G, Kischel R, Bücklein VL, Subklewe M |
Leukemia | 2024 |
Therapy response in AML: a tale of two T cells
Penter L, Wu CJ |
Blood | 2024 |
Membrane Antigen Targeting in Acute Myeloid Leukemia Using Antibodies or CAR-T Cells
Testa U, Castelli G, Pelosi E |
Cancers | 2024 |
Identification of Cellular Senescence-Related Critical Genes and Molecular Classification and Revealing the Drug-Resistant Therapeutic Effect of IGFBP2 in Chronic Myeloid Leukemia
Xu Y, Yang W, Yao F, Wang Z, Liu J, Huang B, Li X, Zhong F, Wang X |
Journal of Inflammation Research | 2024 |
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Barneh F, Koedijk JB, Wijnen NE, Meulendijks T, Ashtiani M, Dunnebach E, Dautzenberg N, Cornel AM, Krippner-Heidenreich A, Klein K, Zwaan CM, Kuball J, Nierkens S, Cloos J, Kaspers GJ, Heidenreich O |
Haematologica | 2024 |
Senescent T Cells: The Silent Culprit in Acute Myeloid Leukemia Progression?
Zhang X, Liu L |
International Journal of Molecular Sciences | 2024 |
Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
Tasis A, Papaioannou NE, Grigoriou M, Paschalidis N, Loukogiannaki C, Filia A, Katsiki K, Lamprianidou E, Papadopoulos V, Rimpa CM, Chatzigeorgiou A, Kourtzelis I, Gerasimou P, Kyprianou I, Costeas P, Liakopoulos P, Liapis K, Kolovos P, Chavakis T, Alissafi T, Kotsianidis I, Mitroulis I |
Cancer Research Communications | 2024 |
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
Mazziotta F, Martin LE, Eagan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung C, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG |
medRxiv | 2024 |
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm
Pelosi E, Castelli G, Testa U |
International journal of molecular sciences | 2023 |
Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia
Huang Y, Zheng H, Zhu Y, Hong Y, Zha J, Lin Z, Li Z, Wang C, Fang Z, Yu X, Liu L, Xu B |
Frontiers in immunology | 2023 |
Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.
Wang P, Zhang Y, Cai Q, Long Q, Pan S, Zhou W, Deng T, Mo W, Wang S, Zhang Y, Wang C, Chen C |
Annals of Medicine | 2023 |
TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
Testa U, Castelli G, Pelosi E |
Mediterranean journal of hematology and infectious diseases | 2023 |
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
Gurska L, Gritsman K |
2023 | |
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Sauerer T, Velázquez GF, Schmid C |
Molecular Cancer | 2023 |
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia
Li Z, Liu X, Wang L, Zhao H, Wang S, Yu G, Wu D, Chu J, Han J |
Frontiers in immunology | 2023 |
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Xiong D, Zhang L, Sun ZJ |
Military Medical Research | 2023 |
The causal relationship between gut microbiota and leukemia: a two-sample Mendelian randomization study.
Chen G, Kuang Z, Li F, Li J |
Frontiers in microbiology | 2023 |
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Tsilingiris D, Vallianou NG, Spyrou N, Kounatidis D, Christodoulatos GS, Karampela I, Dalamaga M |
Current Obesity Reports | 2023 |
Cooperative CAR targeting to selectively eliminate AML and minimize escape.
Haubner S, Mansilla-Soto J, Nataraj S, Kogel F, Chang Q, de Stanchina E, Lopez M, Ng MR, Fraser K, Subklewe M, Park JH, Wang X, Rivière I, Sadelain M |
Cancer Cell | 2023 |
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Vadakekolathu J, Rutella S |
Blood | 2023 |
Present and Future Role of Immune Targets in Acute Myeloid Leukemia
Damiani D, Tiribelli M |
Cancers | 2022 |